STOCK TITAN

Schrodinger, Inc. - $SDGR STOCK NEWS

Welcome to our dedicated page for Schrodinger news (Ticker: $SDGR), a resource for investors and traders seeking the latest updates and insights on Schrodinger stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Schrodinger's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Schrodinger's position in the market.

Rhea-AI Summary
Schrödinger to report Q3 2023 financial results on November 1, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.84%
Tags
-
Rhea-AI Summary
Schrödinger and CUNY institutions receive $1M grant to develop experiential learning opportunities in computational molecular modeling
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
none
-
Rhea-AI Summary
Schrödinger, Inc. grants stock options and restricted stock units to newly hired employees as inducement for employment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.94%
Tags
none
Rhea-AI Summary
Schrödinger to participate in fireside chat at Morgan Stanley conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.42%
Tags
conferences
-
Rhea-AI Summary
Schrödinger, Inc. (SDGR) grants stock options and RSUs to newly appointed chief medical officer and newly hired employees as part of employment compensation, in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options have an exercise price of $39.89 per share and a ten-year term, while the RSUs vest over four years. The grants are subject to the company's 2021 Inducement Equity Incentive Plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.67%
Tags
none
-
Rhea-AI Summary
Schrödinger, Inc. announces financial results for Q2 2023, including total revenue of $35.2 million. The company received FDA clearance for its CDC7 inhibitor SGR-2921 and expects to initiate a Phase 1 clinical study. They also provided updated financial outlook for 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-23.91%
Tags
Rhea-AI Summary
Schrödinger, Inc. (SDGR) reports granting of non-statutory stock options and restricted stock units to newly hired employees as a material inducement to employment. The stock options have an exercise price of $53.35 per share and a ten-year term, while the RSUs vest over four years. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4) and the company’s 2021 Inducement Equity Incentive Plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.09%
Tags
none
-
Rhea-AI Summary
Schrödinger (Nasdaq: SDGR) to Report Q2 2023 Financial Results on August 2, 2023, Hosting Conference Call and Webcast. The company's physics-based computational platform is revolutionizing therapeutics and materials discovery. Access the live webcast and archived webcast on Schrödinger's website. Dial 1-888-440-5983 (Toll-Free) or 1-646-960-0202 (Toll) for the conference call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.65%
Tags
-
Rhea-AI Summary
Schrödinger, Inc. (Nasdaq: SDGR) has granted non-statutory stock options and restricted stock units (RSUs) to 11 newly hired employees. The stock options have an exercise price of $45.98 per share and a ten-year term, vesting over four years. The RSUs also vest over four years, with 25% vesting after 12 months of continuous service and the balance vesting in equal yearly installments over the three-year period following the first anniversary of the employment start date.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.22%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.9%
Tags
conferences
Schrodinger, Inc.

Nasdaq:SDGR

SDGR Rankings

SDGR Stock Data

1.65B
61.36M
2.42%
92.55%
8.62%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
NEW YORK

About SDGR

schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. the predictive power of schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries that might otherwise not be possible. schrödinger also establishes deep partnerships and collaborations with companies in such fields as biotechnology, pharmaceuticals, chemicals, and electronics, and helped found the biotech company nimbus therapeutics. through significant long-term investments in basic research, schrödinger has made scientific breakthroughs across many areas of drug discovery and materials science. hundreds of peer-reviewed scientific publications by schrödinger scientists are frequently among the most heavily cited in their fields. founded in 1990, schrödinger has operations in the us, europe, japan, and india, with business part